SCHEMBL574218

SCHEMBL574218

COC(=O)c1cc(N)c(-c2ccccc2)c(S(=O)(=O)/N=C/N(C)C)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 4/20 0.45
▸ ALDH1A1 P00352 4/20 0.45
▸ KDM4E B2RXH2 3/20 0.45
▸ GAA P10253 3/20 0.45
▸ PKM P14618 1/20 0.45
▸ ACLY P53396 6/20 0.41
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ PTGS2 P35354 1/20 0.36
▸ MAPT P10636 2/20 0.36
▸ GLA P06280 1/20 0.36
▸ CASP1 P29466 1/20 0.36
▸ CASP7 P55210 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL574219 1.00 HPGD (0.45) HPGDALDH1A1KDM4EGAAPKM
SCHEMBL10996368 0.90 GAA (0.43) HPGDALDH1A1KDM4EGAAPKM
SCHEMBL10996371 0.90 GAA (0.43) HPGDALDH1A1KDM4EGAAPKM
SCHEMBL21436402 0.86 KDM4E (0.37) HPGDALDH1A1KDM4EGAAPKM
SCHEMBL11197357 0.86 KDM4E (0.37) HPGDALDH1A1KDM4EGAAPKM
SCHEMBL10998834 0.83 KDM4E (0.42) HPGDALDH1A1KDM4EGAAPKM
SCHEMBL573280 0.83 VCAM1 (0.45) HPGDALDH1A1KDM4EGAAACLY
SCHEMBL573281 0.83 VCAM1 (0.45) HPGDALDH1A1KDM4EGAAACLY
SCHEMBL573731 0.83 HPGD (0.43) HPGDALDH1A1KDM4EGAAPKM
SCHEMBL574175 0.83 HPGD (0.43) HPGDALDH1A1KDM4EGAAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598478-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE Neurotherapeutics Pharma, Inc. (US) 2013-06-05 — — EP disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 — — WO disclosed
Send feedback